3D Breast Ultrasound In Predicting Response to Breast Cancer Therapies
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Breast Cancers
- Sponsor
- University of Michigan
- Enrollment
- 88
- Locations
- 1
- Primary Endpoint
- Volume change on spatially registered (aligned) images tracks path. response better than volume change on unregistered images.
- Status
- Completed
- Last Updated
- 9 years ago
Overview
Brief Summary
The purpose of this study is to determine how well changes can be determined in malignant masses from ultrasound scans.
Detailed Description
To evaluate the proportions of correct diagnosis of response to breast Cancer therapies for localized breast cancer by ultrasound. To develop a model based on patient characteristics, physical exam, and radiologic studies which will predict the possibility that a patient has had a complete pathological response to chemotherapy neoadjuvant therapy.
Investigators
Paul L. Carson Ph.D
Principal Investigator
University of Michigan
Eligibility Criteria
Inclusion Criteria
- •Newly diagnosed breast cancer prior to receiving breast cancer therapy.
- •Diagnosis of breast cancer must be confirmed by fine needle aspiration or core biopsy.
Exclusion Criteria
- •Poorly controlled diabetes.
- •Contralateral mastectomy prior to neoadjuvant chemotherapy.
- •Not a surgical candidate.
- •No previous axillary lymph node dissection.
Outcomes
Primary Outcomes
Volume change on spatially registered (aligned) images tracks path. response better than volume change on unregistered images.
Time Frame: 2002-2014
Self explanatory.
Secondary Outcomes
- Spatially register pre, intra and post treatment ultrasound image volumes of treated tumor.(2002-2014)